Handelsbanken Fonder’s 10x Genomics TXG Stock Holding History

Handelsbanken Fonder’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Hold	46,800	–	–	0.01%	855
2026 Q1	$994K	Hold	46,800	–	–	﹤0.01%	1047
2025 Q4	$763K	Buy	46,800 +11,600	+33%	+$175K	﹤0.01%	1165
2025 Q3	$411K	Hold	35,200	–	–	﹤0.01%	1340
2025 Q2	$408K	Hold	35,200	–	–	﹤0.01%	1328
2025 Q1	$307K	Hold	35,200	–	–	﹤0.01%	1401
2024 Q4	$505K	Buy	35,200 +7,000	+25%	+$110K	﹤0.01%	1284
2024 Q3	$637K	Buy	28,200 +4,100	+17%	+$84.8K	﹤0.01%	1137
2024 Q2	$469K	Buy	24,100 +4,600	+24%	+$120K	﹤0.01%	1186
2024 Q1	$732K	Buy	+19,500	New	+$857K	﹤0.01%	983
2023 Q4	–	Sell	-14,900	Closed	-$615K	–	1605
2023 Q3	$615K	Hold	14,900	–	–	﹤0.01%	948
2023 Q2	$832K	Buy	14,900 +600	+4%	+$32.5K	﹤0.01%	816
2023 Q1	$798K	Hold	14,300	–	–	﹤0.01%	782
2022 Q4	$521K	Hold	14,300	–	–	﹤0.01%	942
2022 Q3	$407K	Hold	14,300	–	–	﹤0.01%	1083
2022 Q2	$647K	Buy	14,300 +1,218	+9%	+$63.2K	﹤0.01%	874
2022 Q1	$995K	Buy	13,082 +900	+7%	+$78.7K	0.01%	803
2021 Q4	$1.81M	Buy	12,182 +4,698	+63%	+$720K	0.01%	647
2021 Q3	$1.09M	Hold	7,484	–	–	0.01%	858
2021 Q2	$1.47M	Sell	7,484 -5,216	-41%	-$944K	0.01%	731
2021 Q1	$2.3M	Sell	12,700 -1,000	-7%	-$173K	0.01%	585
2020 Q4	$1.94M	Buy	+13,700	New	+$1.99M	0.01%	611

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Handelsbanken Fonder's TXG Position: Q2 2026 in Review

Handelsbanken Fonder held its 10x Genomics (TXG) position steady in Q2 2026 at 46,800 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #855.

Handelsbanken Fonder first reported a position in TXG in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.3M in Q1 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Handelsbanken Fonder held 46,800 shares of 10x Genomics worth $1.79M as of Q2 2026.
Handelsbanken Fonder left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #855 holding.
Handelsbanken Fonder first reported a position in 10x Genomics in Q4 2020 and has held it in 22 quarters since.
Handelsbanken Fonder's 10x Genomics position peaked at $2.3M in Q1 2021.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.